JPH10512267A5 - - Google Patents

Info

Publication number: JPH10512267A5
Authority: JP; Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

JP1996521917A

Other languages

English (en)

Other versions

JPH10512267A (ja

JP3665342B2 (ja

Filing date

1996-01-16

Publication date

2004-11-11

1995-01-16 Priority claimed from AUPN0590A external-priority patent/AUPN059095A0/en

1995-01-16 Priority claimed from AUPN0589A external-priority patent/AUPN058995A0/en

1996-01-16 Application filed filed Critical

1996-01-16 Priority claimed from PCT/AU1996/000018 external-priority patent/WO1996022306A1/en

1998-11-24 Publication of JPH10512267A publication Critical patent/JPH10512267A/ja

2004-11-11 Publication of JPH10512267A5 publication Critical patent/JPH10512267A5/ja

2005-06-29 Application granted granted Critical

2005-06-29 Publication of JP3665342B2 publication Critical patent/JP3665342B2/ja

2016-01-16 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

Description

JP52191796A 1995-01-16 1996-01-16 新規ペプチド Expired - Fee Related JP3665342B2 (ja)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
AUPN0590A AUPN059095A0 (en)	1995-01-16	1995-01-16	Novel lipopeptide
AU0589		1995-01-16
AU0590		1995-01-16
AUPN0589A AUPN058995A0 (en)	1995-01-16	1995-01-16	Novel peptide
PCT/AU1996/000018 WO1996022306A1 (en)	1995-01-16	1996-01-16	Novel peptide

Related Child Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2005034053A Division JP2005145985A (ja)	1995-01-16	2005-02-10	新規ペプチド

Publications (3)

Publication Number	Publication Date
JPH10512267A JPH10512267A (ja)	1998-11-24
JPH10512267A5 true JPH10512267A5 (ja)	2004-11-11
JP3665342B2 JP3665342B2 (ja)	2005-06-29

Family

ID=25644844

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
JP52191796A Expired - Fee Related JP3665342B2 (ja)	1995-01-16	1996-01-16	新規ペプチド
JP2005034053A Pending JP2005145985A (ja)	1995-01-16	2005-02-10	新規ペプチド
JP2006002633A Expired - Fee Related JP4522367B2 (ja)	1995-01-16	2006-01-10	新規ペプチド

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
JP2005034053A Pending JP2005145985A (ja)	1995-01-16	2005-02-10	新規ペプチド
JP2006002633A Expired - Fee Related JP4522367B2 (ja)	1995-01-16	2006-01-10	新規ペプチド

Country Status (8)

Country	Link
US (1)	US6057294A (ja)
EP (1)	EP0804469B1 (ja)
JP (3)	JP3665342B2 (ja)
AU (1)	AU694602B2 (ja)
CA (1)	CA2210812C (ja)
DE (1)	DE69617396T2 (ja)
ES (1)	ES2168456T3 (ja)
WO (1)	WO1996022306A1 (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2168456T3 (es) *	1995-01-16	2002-06-16	North Sydney Area Health Serv	Peptidos que afectan a los linfocitos t.
AU2020497A (en) *	1996-03-27	1997-10-17	Susan R. George	Receptor and transporter antagonists
WO1997047644A1 (en) *	1996-06-11	1997-12-18	Northern Sydney Area Health Services	T cell antigen receptor peptides
US20050070478A1 (en) *	1996-06-11	2005-03-31	Northern Sydney Area Health Services	T cell antigen receptor peptides
US6696545B1 (en)	1997-04-11	2004-02-24	Sangstat Medical Corporation	Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
IL132310A0 (en) *	1997-04-11	2001-03-19	Sangstat Medical Corp	Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
AU2001249067A1 (en) *	2000-05-19	2001-12-03	University Of Maryland, Baltimore	Method of use of peptide antagonists of zonulin to prevent or delay the onset ofdiabetes
AU2003210659A1 (en)	2002-01-24	2003-09-02	Sangstat Medical Corporation	Combination therapy for treatment of hiv infection
WO2005115430A1 (en) *	2004-05-27	2005-12-08	Gropep Limited	Treatment of inflammatory airway disease
EP1945658A4 (en) *	2005-09-22	2012-05-30	Yeda Res & Dev	DIASTEREOMERS PEPTIDES FOR MODULATING T-CELL IMMUNITY
EP1870420A1 (en) *	2006-06-23	2007-12-26	Max-Delbrück-Centrum Für Molekulare Medizin	Peptides regulating the surface expression of the T cell receptor
US20120077732A1 (en) *	2008-11-24	2012-03-29	Sydney West Area Health Service	Cyclic peptides and uses thereof
US10138276B2 (en)	2009-09-30	2018-11-27	Signablok, Inc.	Inhibition of TCR signaling with peptide variants
US8513185B2 (en)	2009-10-13	2013-08-20	Alexander B. Sigalov	Inhibition of TREM receptor signaling with peptide variants
WO2018183888A2 (en)	2017-03-31	2018-10-04	The Board Of Trustees Of The Leland Stanford Junior University	Methods of treating t cell exhaustion by inhibiting or modulating t cell receptor signaling
CA3109702A1 (en)	2018-08-13	2020-02-20	Signablok, Inc.	Peptides and compositions for targeted treatment and imaging

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5888512A (en) *	1987-01-30	1999-03-30	Board Of Trustees Of The Leland Stanford Junior University	Lymphocyte activity regulation by HLA peptides
US5223485A (en) *	1989-01-31	1993-06-29	Abbott Laboratories	Anaphylatoxin-receptor ligands
CA2045578A1 (en) *	1989-01-31	1990-08-01	Megumi Kawai	Anaphylatoxin-receptor ligands
KR0185373B1 (ko) *	1989-03-17	1999-05-01	로버트 피. 블랙버언	Hcv 폴리단백질에서 유래되는 hcv 아미노산 서열 부분을 포함하는 폴리펩티드 및 그 사용
AU8228791A (en) *	1990-06-15	1992-01-07	New York University	Heterohybridomas producing human monoclonal antibodies to hiv-1
US5387671A (en) *	1990-12-27	1995-02-07	Abbott Laboratories	Hexa- and heptapeptide anaphylatoxin-receptor ligands
CN1118572A (zh) *	1993-03-05	1996-03-13	萨依特尔有限公司	Hla-a2.1组合肽及其用途
AU1681095A (en) *	1994-01-14	1995-08-01	Matthias Rath	Hydrophilic signal oligopeptides and methods of therapeutic use
US5709995A (en) *	1994-03-17	1998-01-20	The Scripps Research Institute	Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses
AU2238395A (en) *	1994-04-01	1995-10-23	Immulogic Pharmaceutical Corporation	Haptenated peptides and uses thereof
ES2168456T3 (es) *	1995-01-16	2002-06-16	North Sydney Area Health Serv	Peptidos que afectan a los linfocitos t.
US5753625A (en) *	1995-05-12	1998-05-19	Sangstat Medical Corporation	Treatment for inhibiting the progression of autoimmune disease

1996
- 1996-01-16 ES ES96900472T patent/ES2168456T3/es not_active Expired - Lifetime
- 1996-01-16 JP JP52191796A patent/JP3665342B2/ja not_active Expired - Fee Related
- 1996-01-16 AU AU44272/96A patent/AU694602B2/en not_active Ceased
- 1996-01-16 CA CA002210812A patent/CA2210812C/en not_active Expired - Fee Related
- 1996-01-16 EP EP96900472A patent/EP0804469B1/en not_active Expired - Lifetime
- 1996-01-16 DE DE69617396T patent/DE69617396T2/de not_active Expired - Lifetime
- 1996-01-16 US US08/875,013 patent/US6057294A/en not_active Expired - Fee Related
- 1996-01-16 WO PCT/AU1996/000018 patent/WO1996022306A1/en not_active Ceased
2005
- 2005-02-10 JP JP2005034053A patent/JP2005145985A/ja active Pending
2006
- 2006-01-10 JP JP2006002633A patent/JP4522367B2/ja not_active Expired - Fee Related

Publication	Publication Date	Title
JP2000500228A5 (ja)	2004-09-09
JP2000500033A5 (ja)	2004-09-09
JP2000500445A5 (ja)	2004-10-14
JP2000500440A5 (ja)	2004-10-21
JPH11508418A5 (ja)	2004-08-05
JP2000500327A5 (ja)	2005-10-06
JP2000500145A5 (ja)	2004-10-14
JP2000500155A5 (ja)	2004-10-21
JP2000500406A5 (ja)	2004-10-14
JP2000500361A5 (ja)	2004-10-14
JP2000500115A5 (ja)	2004-07-08
JP2000500322A5 (ja)	2004-09-30
JP2000500258A5 (ja)	2004-08-12
JP2000500342A5 (ja)	2004-10-21
JP2000500192A5 (ja)	2004-07-15
JP2000500112A5 (ja)	2004-10-14
JP2000500226A5 (ja)	2004-08-12
JP2000500051A5 (ja)	2004-10-14
JP2000500166A5 (ja)	2004-09-24
JP2000500397A5 (ja)	2004-10-21
JP2000500407A5 (ja)	2004-10-21
JP2000500125A5 (ja)	2004-10-21
JP2000500044A5 (ja)	2006-01-05
JP2000500346A5 (ja)	2005-06-16
JP2000500090A5 (ja)	2005-11-24